Medical device and digital health companies must navigate a complex web of cybersecurity requirements when seeking FDA approval. As healthcare products become more interconnected, regulators have intensified their scrutiny of cybersecurity measures—and for good reason. A single vulnerability could jeopardise patient safety, privacy, and clinical functionality.
At Periculo, we have successfully guided numerous medical device companies through the FDA submission process. We have distilled our expertise into this comprehensive guide to help you confidently meet pre-market cybersecurity requirements.
The FDA’s approach to cybersecurity has evolved significantly in recent years. In 2023, the agency published its final guidance, Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions, setting forth more rigorous expectations for manufacturers.
Today’s submissions require more comprehensive documentation, threat modelling, and security controls than ever before. Below, we outline the essential steps for compliance.
The FDA expects manufacturers to systematically identify threats, vulnerabilities, and risks to their devices.
Asset: Bluetooth communication module
Threat: Man-in-the-middle attack intercepting patient data
Vulnerability: Lack of encryption for transmitted data
Risk Level: High (Severity: High, Likelihood: Medium)
Mitigation: Implement AES-256 encryption for all data transmission
Pro Tip: The STRIDE model (Spoofing, Tampering, Repudiation, Information Disclosure, Denial of Service, Elevation of Privilege) is a structured approach that aligns well with FDA expectations.
Manufacturers must demonstrate that security considerations were integrated throughout the development lifecycle.
Security Requirement SR-042: The device must authenticate users before granting access to protected health information (PHI).
Implementation: Multi-factor authentication (biometric and password components).
Verification Method: Penetration testing (Report #PT-2024-113).
Result: Passed—unable to access PHI without valid authentication.
Pro Tip: Referencing established frameworks such as Microsoft SDL or OWASP SAMM demonstrates maturity in your security development process.
Manufacturers must have a documented process for ongoing cybersecurity risk management.
Risk Management Process: Risk assessment conducted at design milestones using CVSS scoring.
Risk Acceptance Criteria: CVSS scores above 7.0 require mitigation before submission.
Verification Approach: Independent penetration testing by a qualified third party.
Post-Market Monitoring: Subscription to US-CERT, ICS-CERT, and CVE monitoring services.
Pro Tip: Align your risk management strategy with ISO 14971 to ensure integration with overall product risk management.
Manufacturers must provide evidence of security controls addressing identified risks.
Pro Tip: Organise your documentation using the NIST Cybersecurity Framework for a structured and FDA-aligned submission.
A complete inventory of software components, including third-party and open-source elements.
Pro Tip: Use SPDX or CycloneDX formats to ensure industry-standard compliance.
A comprehensive report summarising cybersecurity measures and findings.
Pro Tip: Present your cybersecurity measures as a coherent narrative to help reviewers understand your security-by-design approach.
A structured approach to managing cybersecurity risks after product launch.
Pro Tip: A robust post-market cybersecurity plan can significantly streamline the FDA review process.
Navigating the FDA’s cybersecurity requirements demands a methodical, well-documented approach. By following this step-by-step guide, you can develop a submission that not only meets regulatory expectations but also enhances your product’s overall security.
At Periculo, we specialise in guiding medical device companies through complex cybersecurity requirements. If you need expert support in preparing your FDA submission, contact our team for a complimentary initial consultation.